Evidence map›Paper›PMID 31898828›Full record

ArticleHuman mutation2020

Loss of RAD9B impairs early neural development and contributes to the risk for human spina bifida.

Xuanye Cao, Tian Tian, John W Steele, Robert M Cabrera, Vanessa Aguiar-Pulido, Shruti Wadhwa, Nikitha Bhavani, Patrick Bi, Nick H Gargurevich, Ethan N Hoffman and 7 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Human mutation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Xuanye CaoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Tian TianDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
John W SteeleDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Robert M CabreraDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Vanessa Aguiar-PulidoCenter for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York City, New York.
Shruti WadhwaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Nikitha BhavaniDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Patrick BiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Nick H GargurevichDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Ethan N HoffmanDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Chun-Quan CaiDepartment of Neurosurgery, Tianjin Children's Hospital, Tianjin, China.
Nicholas J MariniDepartment of Molecular and Cellular Biology, California Institute for Quantitative Biosciences, University of California, Berkeley, California.
Wei YangDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California.
Gary M ShawDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California.
Margaret E RossCenter for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York City, New York.ORCID 0000-0001-6440-8089
Richard H FinnellDepartments of Molecular and Human Genetics, Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-5962-8754
Yunping LeiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-1504-0884
Baylor College of Medicine · USCornell University · USStanford University · USQB3 · USTianjin Children's Hospital · CN

Funding

Risk Genes and Environment Interactions in NTDsP01HD067244 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROSS, MARGARET ELIZABETH · 2011 to 2020
$12.6M
INTERVENTION STRATEGIES FOR NON-FOLATE RESPONSIVE NEURAL TUBE DEFECTSR01HD083809 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI FINNELL, RICHARD H. · 2016 to 2024
$5.1M
California Center of BD-STEPS - Finding Causes and Preventives of Birth DefectsU01DD001033 · DD · STANFORD UNIVERSITY · PI CARMICHAEL, SUZAN L, SHAW, GARY M · 2013 to 2017
$3.4M
Biomechanics of Neural Tube Development using Brillouin-OCT MultimodalityR01HD095520 · NICHD · UNIVERSITY OF HOUSTON · PI FINNELL, RICHARD H., LARIN, KIRILL V · 2018 to 2022
$3.3M
Folic Acid, Parental Mutation Rates and the Risk for Neural Tube DefectsR01HD081216 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI FINNELL, RICHARD H., LEI, YUNPING · 2015 to 2019
$2.5M
Genetic Risk for Orofacial Clefts in the Folate/Homocysteine PathwayR01HD074695 · NICHD · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARINI, NICHOLAS · 2013 to 2016
$2.0M
CDC HHS CU01DD001033NCBDD CDC HHS U01 DD001033NICHD NIH HHS P01 HD067244NICHD NIH HHS R01 HD074695NICHD NIH HHS R01 HD081216NICHD NIH HHS R01 HD083809NICHD NIH HHS R01 HD095520
6 · The paper itself

Abstract

DNA damage response (DDR) genes orchestrating the network of DNA repair, cell cycle control, are essential for the rapid proliferation of neural progenitor cells. To date, the potential association between specific DDR genes and the risk of human neural tube defects (NTDs) has not been investigated. Using whole-genome sequencing and targeted sequencing, we identified significant enrichment of rare deleterious RAD9B variants in spina bifida cases compared to controls (8/409 vs. 0/298; p = .0241). Among the eight identified variants, the two frameshift mutants and p.Gln146Glu affected RAD9B nuclear localization. The two frameshift mutants also decreased the protein level of RAD9B. p.Ser354Gly, as well as the two frameshifts, affected the cell proliferation rate. Finally, p.Ser354Gly, p.Ser10Gly, p.Ile112Met, p.Gln146Glu, and the two frameshift variants showed a decreased ability for activating JNK phosphorylation. RAD9B knockdowns in human embryonic stem cells profoundly affected early differentiation through impairing PAX6 and OCT4 expression. RAD9B deficiency impeded in vitro formation of neural organoids, a 3D cell culture model for human neural development. Furthermore, the RNA-seq data revealed that loss of RAD9B dysregulates cell adhesion genes during organoid formation. These results represent the first demonstration of a DDR gene as an NTD risk factor in humans.

Indexed as

Genetic Predisposition to DiseaseCase-Control StudiesCell Cycle ProteinsCell LineDNA DamageDNA RepairEmbryonic Stem CellsFluorescent Antibody TechniqueGene ExpressionHumansLoss of Function MutationMutationNeural Tube DefectsNeuronsRisk AssessmentRisk FactorsCell Cycle Proteinsrad9 proteinDNA damage responseRAD9Bspina bifidastem cell

Identifiers

PMID31898828
PMCPMC7185173
OpenAlexW2998551848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.